Cargando…

Morbid Obesity Is Associated With Worse Outcomes and Increased Inpatient Mortality in Patients With Alcohol Induced Acute Pancreatitis

Introduction: The prevalence of obesity in the United States is rising. Obesity is a known comorbidity with various health impacts. Alcohol is a common etiology for acute pancreatitis. Obesity is known to be associated with liver dysfunction. It is unclear to what extent the degree of obesity affect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaka, Hafeez, Rashad, Essam, Achebe, Ikechukwu, Asotibe, Jennifer Chiagoziem, Palomera, Emmanuel, Pudasaini, Garima, Warraich, Muhammad-Sheharyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089142/ http://dx.doi.org/10.1210/jendso/bvab048.042

Ejemplares similares

Impact of Morbid Obesity on Patients With Hypertriglyceridemia Induced Acute Pancreatitis
por: Pudasaini, Garima, et al.
Publicado: (2021)

Morbid Obesity Does Not Impact Mortality, Rate of Endoscopy in Patients With Biliary Acute Pancreatitis: A US Nationwide Analysis
por: Shaka, Hafeez, et al.
Publicado: (2021)

Obesity Is Associated With Higher odds of Hepatorenal syndrome in Patients Admitted With Alcoholic Hepatitis: Analysis of the National Inpatient Sample (2016–2017)
por: Asotibe, Jennifer Chiagoziem, et al.
Publicado: (2021)

Endocrine and Metabolic Comorbidities in Hospitalized Psoriasis Patients in the United States
por: Edigin, Ehizogie, et al.
Publicado: (2021)

Metabolic and Endocrine Comorbidities in Hidradenitis Suppurativa: A Nationwide Study
por: Edigin, Ehizogie, et al.
Publicado: (2021)

FRI044 Racial Differences In Outcomes Of Hospitalizations For COVID-19 With Morbid Obesity: Insights From The National Inpatient Sample
por: Gajjar, Rohan Ashwinbhai, et al.
Publicado: (2023)

RF24 | PSUN108 Inpatient and Readmission Outcomes Following Endoscopic Gastrectomy Versus Gastrojejunostomy in Patients with Morbid Obesity: A Nationwide Retrospective Analysis
por: Abusalim, Abdul-rahman, et al.
Publicado: (2022)

Higher Inpatient Morbidity and Mortality in Biliary Pancreatitis Compared to Hypertriglyceridemia-Induced Pancreatitis: A Nationwide Retrospective Study
por: Shaka, Hafeez, et al.
Publicado: (2020)

FRI043 The Double Pandemic Effect Of Obesity And COVID-19 Among United States Adult Hospitalizations: Outlining Hospitalization Outcomes Of A Synergistic Catastrophe
por: Shaka, Hafeez, et al.
Publicado: (2023)

PSUN119 Obesity As An Independent Factor In Outcome Of SIADH Hospitalizations
por: Maghari, Ibrahim, et al.
Publicado: (2022)

MON-592 The Impact of Bariatric Surgery on the Risk of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients
por: Borges-Canha, Marta, et al.
Publicado: (2020)

FRI045 Impact Of Morbid Obesity On Lupus Hospitalizations: A Nationwide Analysis
por: Sami, Faria, et al.
Publicado: (2023)

SAT673 Novel Mutation Of TBX3 Associated With Morbid Obesity In Human
por: Alkaissi, Hussam R, et al.
Publicado: (2023)

MON-LB100 Novel Paradoxical Markers of Weight Loss: Is the Worse Actually the Better? a Retrospectiveanalysisof 1,567 Patientswith Obesity With Successful Clinical Weight-Loss Approaches
por: Cadegiani, Flavio, et al.
Publicado: (2020)

MON-603 GPR142 Expression Levels Were Correlated with Plasma Ghrelin Levels and Heights in Morbidly Obese Patients
por: Ueda, Yoko, et al.
Publicado: (2020)

MON-LB101 5-Year Data of an Aggressive Pharmacological Approach to Moderate and Morbid Obesity: Is Prevention of Bariatric Surgery Feasible in the Long Run?
por: Cadegiani, Flavio
Publicado: (2020)

FRI047 Clinical Characteristics Of Patients With Morbid Obesity With Semaphorines (SEMA3D,E,G) And PLXNA3&4 Gene Variants
por: Berra, Maddie, et al.
Publicado: (2023)

SUN-LB103 The Relationship Between Alcohol Consumption Patterns and Insulin Sensitivity in Obesity
por: Han, Katrina, et al.
Publicado: (2020)

Are Obese Patients Evaluated for Non-Alcoholic Fatty Liver Disease in an Endocrinology Outpatient Clinic?
por: Irazusta, Florencia, et al.
Publicado: (2021)

SAT-LB016 Diabetes and Non-Alcoholic Fatty Liver Disease in Two Patients with ROHHAD Syndrome
por: Sprague, Jennifer, et al.
Publicado: (2019)

Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese Type Two Diabetes Patients in an Endocrine Clinic
por: Shaghouli, Amna Ali, et al.
Publicado: (2021)

MON-597 Non-Alcoholic Fatty Liver Disease Determined by MRI and Its Association with Metabolic Variables in Non-Diabetic Subjects
por: Da Silva, Debora Gonçalves, et al.
Publicado: (2020)

Leptin Decreases Energy Expenditure but Increases Thyroid Hormone in Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2021)

SAT-LB020 Use of Ultrasound to Characterize Abdominal Adipose Tissue Distribution and Its Impact on Metabolic Syndrome
por: Cuatrecasas Cambra, Guillem, et al.
Publicado: (2019)

MON-099 Age-Related Differences in Appetite Regulation among Adults with Obesity: More Than Just Hunger and PYY and Ghrelin? Oh My!
por: Iwamoto, Sean, et al.
Publicado: (2019)

MON-101 The LD Lync Study: Natural History Study of Lipodystrophy Syndromes: Early Lessons from the Pilot Data
por: Jalal Eldin, Abdelwahab, et al.
Publicado: (2019)

MON-114 Effect of Selective Mineralocorticoid Receptor Antagonist on liver Fat and Metabolism in Patients with Type 2 Diabetes: A Randomized Controlled Trail
por: Kistorp, Caroline, et al.
Publicado: (2019)

MON-092 Role of Genetic Variants of NNMT rs694539 and rs1941404, FTO rs1421085 and Irx3 rs3751723 Polymorphisms on Resting Energy Expenditure and BMI
por: Bañales Luna, Maciel, et al.
Publicado: (2019)

MON-113 Taste Sensitivity is Related to Incretin Response to Oral Glucose Challenge, Dietary Habits and Body Composition: A Novel Link with Energy Metabolism
por: Dagdelen, Selcuk, et al.
Publicado: (2019)

MON-106 Prevalence of Abdominal Obesity According to Different Cutoff Points in the Peruvian Population Living at Different Altitudes
por: Pajuelo-Ramirez, Jaime, et al.
Publicado: (2019)

MON-115 Acute BAT Activation Improves Glucose Tolerance and Beta-Cell Secretion and Facilities Lipid over Glucose Utilization in Obese Metabolically Healthy Males
por: Bertozzi, Beatrice, et al.
Publicado: (2019)

MON-098 FSH and Body Composition in Older Adults
por: Woods, Gina, et al.
Publicado: (2019)

MON-104 Defining the Contribution of Weight to the Extent of Metabolic Disease in FPLD: Insights from a Retrospective "Matched" Case-Control Study
por: Koo, Eden, et al.
Publicado: (2019)

SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management.
por: Parziale, Andrew, et al.
Publicado: (2019)

SAT-LB017 Anthropometric Imaging and Biological Markers of Adiposity and Aldosterone among African Americans: The Jackson Heart Study
por: Lee, Grace, et al.
Publicado: (2019)

MON-096 Body Composition in Patients with Craniopharyngioma: Is DXA-Scanning Necessary for Evaluating the Metabolic Syndrome?
por: van Santen, Selveta, et al.
Publicado: (2019)

MON-118 Biochemical and Clinical Correlates of Subcutaneous Adipose mRNA Transcript Levels in Men with T2DM
por: Tun, Nyo Nyo, et al.
Publicado: (2019)

MON-110 A Natural Compound Isolated from Schisandra Chinensis Fruit Has a Beneficial Effect in a Fly Model of Obesity
por: Cheon, Chong Kun, et al.
Publicado: (2019)

MON-109 Identifying Limiting Factors to Weight Loss and Prevention of Comorbidities in a Patient Population with Obesity
por: Johns, Allison, et al.
Publicado: (2019)

MON-LB018 Depot-Specific Differences in Adipose Tissue Morphology with Laron Syndrome
por: Geitgey, Delaney, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f11hlfrof81hufg9ab2t89r56j